Apoptosis of eosinophils and lymphocytes in allergic inflammation

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 1, 1999, Pages 14-21

  Ohta, Ken ^a   Yamashita, Naomi ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Allergic inflammation; Apoptosis; Asthma; Corticosteroids; Eosinophils; GM CSF; IL 5; Lymphocytes; Phosphodiesterase inhibitors; Theophylline

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; BUCLADESINE; CORTICOSTEROID; CYCLIC AMP; FORSKOLIN; INTERLEUKIN 5; ROLIPRAM; THEOPHYLLINE;

ALLERGIC ASTHMA; ALLERGIC REACTION; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CORTICOSTEROID THERAPY; EOSINOPHIL; HUMAN; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032838480     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70107-7     Document Type: Article

References (57)

1. 1. Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivitiy in patients with asthma. Am Rev Respir Dis 1985;131:599-606.
2. 2. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma. An ultrastructural, qualitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-53.
3. 3. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:697-704.
4. 4. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
5. 5. Gleich GJ. The eosinophil and bronchial asthma. J Allergy Clin Immunol 1990;85:422-36.
6. 6. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
7. 7. Rabe KF, Dent G. Theophylline and airway inflammation. Clin Exp Allergy 1998;28(suppl 3):35-41.
8. 8. Raff MC. Social controls on cell survival and cell death. Nature 1992;356:397-400.
9. 9. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implication in tissue kinetics. Br J Cancer 1972;26:239-57.
10. 10. Cohen JJ. Apoptosis. Immunol Today 1993;14:126-30.
11. 11. Wyllie AH, Kerr JF, Currie AR. Cell death. The significance of apoptosis. Int Rev Cytol 1980;68:251-306.
12. 12. Nieto MA, Lopez-Rivas A. IL-2 protects T-lymphocytes from glucocorticoid-induced DNA fragmentation and cell death. J Immunol 1989;143:4166-70.
13. 13. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-56.
14. 14. Schultze-Osthoff K, Krammer PH, Droge W. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J 1994;13:4587-96.
15. 15. Varfolomeev EE, Boldin MP, Goncharov TM, Wallach D. A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other. J Exp Med 1996;183:1271-5.
16. 16. Ryan JJ, Prochownik E, Gottlieb CA, Apel IJ, Merino R, Nunez G, et al. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA 1994;91:5878-82.
17. 17. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;369:609-19.
18. 18. Bousquet J, Chanez P, Lacoste JY, Arnéon G, Ghavanion N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
19. 19. Kay AB, Barata L, Meng Q, Durham SR, Ying S. Eosinophils and eosinophil-associated cytokines in allergic inflammation. Int Arch Allergy Immunol 1997;113:196-9.
20. 20. Kitamura T, Miyajima A. Functional reconstitution of the human interleukin-3 receptor. Blood 1992;80:84-90.
21. 21. Tai P-C, Sun L, Spry CFJ. Effects of IL-5, GM-CSF and IL-3 on survival of human blood eosinophils in vitro. Clin Exp Immunol 1992;85:312-6.
22. 22. Her E, Frazer J, Austin KF, Owen WF. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. J Clin Invest 1991;88:1982-7.
23. 23. Yamaguchi Y, Suda T, Ohata S, Tominaga K, Miura Y, Kasahara T. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991;78:2542-7.
24. 24. Dent LA, Strath M, Mellor AL, Sandeerson CJ. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 1990;172:1425-31.
25. 25. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
26. 26. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991;173:775-8.
27. 27. Yamaguchi Y, Sudo T, Ohata S, Tominaga K, Miura Y, Kasa T. Analysis of the survival of mature human eosinophils: Interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991;78:2542-7.
28. 28. Ohta K, Sawamoto S, Nakajima M, Kubota S, Tanaka Y, Miyasaka T, et al. The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis. Clin Exp Allergy 1996;26(suppl 2):10-5.
29. 29. Hallsworth MP, Litchfield TM, Lee TH. Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils. Immunology 1992;75:382-5.
30. 30. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996;156:4422-8.
31. 31. Fried J, Perez AG, Clarkson BD. Rapid hypotonie method for flow cytofluorometry of monolayer cell cultures. J Histochem Cytochem 1998;26:921-33.
32. 32. Djukanovic R, Wilson JW, Britten YM, Wilson SJ, Walls AF, Roche WF, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms of asthma. Am Rev Respir Dis 1992;143:669-74.
33. 33. Adachi T, Motojima S, Hirata A, Fukuda T, Kihara N, Kosaku A, et al. Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5. J Allergy Clin Immunol 1996;98:S207-15.
34. 34. Bergstrand H. Phosphodiesterase inhibition and theophylline. Eur J Respir Dis 1980;61(suppl 109):37-44.
35. 35. Ohta K, Kubota S, Nakajima M, Sawamoto S, Miyasaka T, Nakajima Y, et al. Phosphodiesterase (PDE) inhibitors can suppress prolonged survival of eosinophils with interleukin-5 (IL-5). J Allergy Clin Immunol 1997;99:S356.
36. 36. Hallsworth, Giembycz MA, Barnes PJ, Lee TH. Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF. Br J Pharmacol 1996;117:79-86.
37. 37. Yasui K, Hu B, Nakazawa T, Agematsu K, Komiyama A. Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. J Clin Invest 1997;100:1677-84.
38. 38. Shute JK, Tenor H, Church MK, Holgate ST. Theophylline inhibits the release of eosinophil survival cytokines - Is Raf-1 the protein kinase A target? Clin Exp Allergy 1998;28(suppl 3):47-52.
39. 39. Neito MA, Lopez-Rivas A. Glucocorticoids activate a suicide program in mature T lymphocytes: protective action of interleukin-2. Ann NY Acad Sci 1992;650:115-20.
40. 40. Northrop JP, Crabtree GR, Mattila PS. Negative regulation of interleukin 2 transcription by the glucocorticoid receptor. J Exp Med 1992;175:1235-45.
41. 41. Almawi WY, Lipman ML, Stevens AC, Zanker B, Hadro ET, Strom TB. Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-g. Immunology 1991;146:3523-7.
42. 42. Leung DYM, de Castro M, Szefler SJ, Chrousos GP. Mechanisms of glucocorticoid-resistant asthma. Ann NY Acad Sci 1998;840:735-46.
43. 43. Huang RW, Tsuda H, Takatsuki K. Interleukin-2 prevents programmed cell death in chronic lymphocytic leukemia cells. Int J Hematol 1993;58:83-92.
44. 44. Mentz F, Merle-Beral H, Ouaaz F, Binet JL. Theophylline, a new inducer of apoptosis in B-CLL: role of cyclic nucleotide. Br J Haematol 1995;90:957-9.
45. 45. Mentz F, Mossalayi MD, Ouaaz F, Baudet S, Issaly F, Ktorza S, et al. Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells. Blood 1996;88:2172-82.
46. 46. Lømo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB. TGF-b1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol 1995;154:1634-43.
47. 47. Kizaki H, Suzuki K, Tadakuma T, Ishimura Y. Adenosine receptor-mediated accumulation of cyclic AMP-induced T-lymphocyte death through internucleosomal DNA cleavage. J Biol Chem 1990;265:5280-4.
48. 48. Jiang X, Li J, Paskind M, Epstein PM. Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells. Proc Natl Acad Sci USA 1996;93:11236-41.
49. 49. Mentz F, Baudet S, Blanc C, Issaly F, Binet JL, Merle-Beral H. Simple, fast method of detection apoptosis in lymphoid cells. Cytometry 1998;32:95-101.
50. 50. Kim DH, Lerner A. Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia. Blood 1998;92:2484-94.
51. 51. Tsuyuki S, Bertrand C, Erard F, Trifilieff A, Tsuyuki J, Wesp M, et al. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J Clin Invest 1995;96:2924-31.
52. 52. Kawabori S, Soda K, Perdue MH, Bienenstock J. The dynamics of intestinal eosinophil depletion in rats treated with dexamethasone. Lab Invest 1991;64:224-33.
53. 53. Woolley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH, Woolley MJ. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 1996;154:237-43.
54. 54. Sullivan P, Bekir S, Jaffaer Z, Page C, Jeffery P, Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994;343:1006-8.
55. 55. Kidney J, Domiguez M, Taylor PM, Rose M, Chung KF, Barnes PJ. Immunomodulation by theophylline in asthma: demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995;151:1907-14.
56. 56. Nassif EG, Weinberger M, Thompson R, Huntley W. The value of maintenance theophylline in steroid-dependent asthma. N Engl J Med 1981;304:71-5.
57. 57. Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997;337:1412-8.